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Wolfgang Lutz6, Wolfgang Greiner7, Martin Hautzinger8, Matthias Rose9, Viola Gräfe7, Fritz Hohagen1,
Gerhard Andersson10,11, Eik Vettorazzi12 and Steffen Moritz3Abstract
Background: Depressive disorders are among the leading causes of worldwide disability with mild to moderate
forms of depression being particularly common. Low-intensity treatments such as online psychological treatments
may be an effective way to treat mild to moderate depressive symptoms and prevent the emergence or relapse of
major depression.
Methods/Design: This study is a currently recruiting multicentre parallel-groups pragmatic randomized-controlled
single-blind trial. A total of 1000 participants with mild to moderate symptoms of depression from various settings
including in- and outpatient services will be randomized to an online psychological treatment or care as usual
(CAU). We hypothesize that the intervention will be superior to CAU in reducing depressive symptoms assessed
with the Personal Health Questionnaire (PHQ-9, primary outcome measure) following the intervention (12 wks) and
at follow-up (24 and 48 wks). Further outcome parameters include quality of life, use of health care resources and
attitude towards online psychological treatments.
Discussion: The study will yield meaningful answers to the question of whether online psychological treatment
can contribute to the effective and efficient prevention and treatment of mild to moderate depression on a
population level with a low barrier to entry.
Trial registration: Trial Registration Number: NCT01636752
Keywords: Subclinical depression, Major depression, Prevention, Treatment, Online psychological treatment,
Self-help, Guided self-help, Randomized controlled trial, Health economic evaluation, Cost-of-illness analysisBackground
Depressive disorders are among the leading causes of
worldwide disability [1]. Mild to moderate forms of depres-
sion are even more common than severe depression. While
29% of primary care patients reported mild to moderate de-
pressive symptoms in one study only 9.5% reported moder-
ate to severe symptoms [2]. However, subclinical forms of
depression are associated with considerable impairment,* Correspondence: philipp.klein@uksh.de
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stated.economic costs, and increased risk for developing major
depression [3-5].
Consequently, preventing depression and increasing
access to treatment are among the most urgent global
health care priorities [6,7]. Unfortunately, many individ-
uals with depression remain untreated, even in coun-
tries with well-developed health care systems. The
global mental health treatment gap has been estimated
at 50% for all mental disorders [7,8]. To bridge this
treatment gap and improve depression prevention and
treatment, a wide array of innovative methods are
needed [9]. These can be employed in a stepped-cared. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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to patients’ current symptom severity [10].
Stepped-care models have been adopted in some na-
tional treatment guidelines, such as those by the National
Institute of Clinical Excellence in the United Kingdom
[10,11]. In such guidelines, low-intensity interventions are
regarded as an appropriate first option for patients with
mild to moderate depressive symptoms [10] p. 16. The
spectrum of low-intensity treatments spans from self-help
books to brief counseling. It includes interventions deliv-
ered by phone, mail, or SMS; or guided and unguided
online psychological treatments [12]. Research on online
depression treatments has garnered particular momentum
in recent years, and a number of meta- analyses and sys-
tematic reviews attest to their efficacy [13-19].
Online psychological treatments have been noted to
have several advantages, including easy accessibility and
scalability, such that vast segments of the population can
potentially be reached at low cost [20]. Not all internet in-
terventions are easily scalable, though. Broadly speaking,
the internet can be used as a communication channel as
well as an information medium [20,21]. Used as a commu-
nication medium (in chat-therapy, for instance), it makes
treatment more accessible for patients. However, in this
form of internet-mediated intervention, therapists are still
required to devote considerable time to each patient.
When used as a pure information medium (i.e. unguided
online self-help), treatment is both easily accessible and
can be scaled up because demands on therapist time are
minimized.
Meta-analyses have shown that self-guided programs,
which do not require therapist support, are effective in the
treatment of depressive symptoms, albeit with small effect
sizes [22]. The effectiveness of unguided self-help pro-
grams can also be compromised by a high drop-out rate.
In guided forms of online self-help, therapists motivate
and support patients regularly, for example via brief
weekly e-mail contacts. Guided online depression inter-
ventions have been shown to achieve medium to large ef-
fect sizes [13,16]. One meta-analysis even demonstrated
that guided self-help can be as effective as face-to-face
treatment [15]. Contacting patients prior to the onset of
treatment for diagnostic purposes may increase the effect
of unguided self-help programs to a medium effect size
[16]. Online psychological treatments have also success-
fully been studied in the prevention of depressive disor-
ders [23] and the prevention of relapse [24,25].
Even though the evidence base supporting the efficacy
of online depression treatments has grown in recent years,
previous studies are limited by various methodological fac-
tors. Firstly, many studies relied solely on self-reports and
lacked interview-based instruments to establish diagnoses
and measure symptom severity [22]. Secondly, recruit-
ment was often carried out via advertisements or theinternet rather than through clinical settings, which may
introduce a bias towards more internet-savvy or motivated
participants. Thirdly, most previous studies were carried
out by single study sites, and the researchers were also fre-
quently the developers of the online intervention, which
may limit generalizability and foster allegiance effects.
Fourthly, sample sizes in many previous studies were too
small to examine moderator effects. Finally, no study to
date has investigated the effect of internet-based depression
treatment on subsequent help-seeking behavior. Further-
more, there is no published study known to the authors
which examines the health economic consequences of
internet-based treatment of depression in the German
context.
We will therefore conduct a large multicenter trial to
test the effectiveness of an online-based psychological
treatment, compared to a care as usual control condition,
among adults suffering from mild to moderate depressive
symptoms, the EVIDENT trial (EffectiVeness of Internet-
based DEpressioN Treatment). In this trial, mild to mod-
erate depressive symptoms are operationalized as a score
between 5 and 14 on the Patient Health Questionnaire
(PHQ-9) [26]. Whereas participants with mild depressive
symptoms (PHQ-9 score 5–9) will receive an unguided
version of an online treatment, those with moderate
symptoms (PHQ-9 score 10–14) will receive additional
e-mail-support. Subjects will be recruited from a broad
array of settings, including in- and outpatient medical
and psychological services but also online-forums for
depression, health-insurance companies and the general
media (e.g., coverage in newspaper and radio reports).
We will thus also be able to examine if and how online
psychological treatments can be integrated into regular
in- and outpatient settings.
We hypothesize that online psychological treatment
will be superior to a care as usual control condition in re-
ducing mild-to-moderate depressive symptoms. We will
also analyze the effect of the intervention on the risk of de-
veloping a depressive episode in the treatment phase and
in the follow-up period, which will extend to one year. We
will thus be able to ascertain the effect of the intervention
on the prevention of a depressive episode. Further outcome
parameters include quality of life and attitude towards on-
line psychological treatments. Moreover a cost-of-illness
analysis will be conducted to determine the consumption
of resources of patients with depression symptoms – separ-
ately analysed by different health care sectors.
Methods
Study design
This study is a parallel-groups pragmatic randomized
controlled single-blind trial. Subjects will be randomized
into two groups: (1) Care-as-usual (CAU) or (2) CAU
plus online-based psychological treatment. Participants
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will receive access to an unguided online psychological
treatment, whereas those with moderate symptoms will
receive the same treatment plus e-mail support (guided
self-help). The study is being conducted in compliance
with the Declaration of Helsinki [27]. It has been approved
by the Ethics Committee of the German Psychological
Association (DGPs, reference number SM 04_2012). All
participants receive written information about the aim
of the study, benefits and risks of participation and the
study procedure. They are informed that they can with-
draw at any time without having to disclose reasons. In-
formed consent will be obtained online prior to the
baseline assessment. A written study protocol has been
developed. Results will be reported in accordance with the
CONSORT guidelines [28]. The study design is shown in
Figure 1.
Setting
A total of 1000 participants with symptoms of mild to
moderate depression will be recruited via multiple
settings, including in- and outpatient medical and psy-
chological clinics, online-forums for depression, health-
insurance companies and the media (e.g., newspaper
and radio). The central recruitment tool is a study web-
site (www.online-studie-depression.de), where inter-
ested persons can register for participation. Posters and
postcards advertising the study are also distributed in
potential recruitment sites (e.g., clinics). For the recruit-
ment in online-forums, a standardized message adver-
tising the study and referring to the study website will
be posted in depression-specific forums by one of the
coordinating centers. Participating health-insuranceInformed Consent
Pre-Screening for Eligibility(self report)
Screening for Eligibility and Baseline 
(T1) (clinical interview)
Randomization (50:50) (stratified by 
depression severity; Ntargetl=1000)
Care as Usual
Online Psychological Treatm
Ntarget=500)
Care as Usual plus Online 
Psychological Treatment
(PHQ>10: E-Mail-Support; Ntarget=500)
Posttreatment Assessment (T2) (self report and clinical intervie
Nexpected=800)
First Follow-Up Assessment (T3) (self report; 24 wk
Second Follow-Up Assessment (T4) (self report and clinical i
wks.; Nexpected=600)
Figure 1 Diagram of patient flow through the phases of study [28].companies will advertise the study on their websites and
in their magazines. They will also be asked to support
the analysis of health care resource use described below.
Inclusion and exclusion criteria
The main inclusion criterion for this study is the presence
of mild to moderate depressive symptoms, operationalized
as a score between 5 and 14 on the PHQ-9 [26]. Partici-
pants are required to be between 18and 65 years of age,
have internet-access and be able to communicate in
German. The main exclusion criteria are acute suicidality
and a lifetime diagnosis of bipolar disorder or schizophre-
nia. The presence of these diagnoses will be assessed using
the Mini International Neuropsychiatric Interview [MINI:
29] via telephone. Acute suicidality will be assessed clinic-
ally based on a structured assessment of current suicidal
ideation and past suicide attempts [29-31]. Participants
who do not meet our inclusion criteria due to severity of
illness are encouraged to seek professional help.
Randomization
Subjects will be randomized to two groups (intervention or
CAU) after completion of the baseline assessment (online
questionnaires and clinical interview via telephone). Strati-
fication at one level will be performed by severity of de-
pressive symptoms. The stratification is designed to ensure
equal allocation of participants with mild depressive symp-
toms (PHQ-9: 5–9) and moderate depressive symptoms
(PHQ-9: 10–14) to each of the two study arms. Block
randomization with variable block sizes is used. An inde-
pendent researcher created the allocation schedule with a
computerized random number generator; other investiga-
tors are blind to this schedule. Allocation is concealed, i.e.Exclusion following Pre-Screening
• PHQ <5
• PHQ >14
• age <18 or >65
Exclusion following Screening
• acute suicidality
• hx of mania or psychosis
 (access to 
ent after T4; 
w; 12 wks.; 
s)
nterview; 48 
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therefore no control over, the group to which a patient
may be allocated. Subjects are informed about the
randomization outcome via an email that is automatic-
ally sent to participants after the diagnostic interviewer
has confirmed that inclusion- and exclusion criteria
have been met. The automated email contains a code
with which participants randomized to the intervention
group can immediately start with the treatment. Diag-
nostic interviewers will be kept blind to the group as-
signment of the participants.
Intervention
Intervention group
Participants in the intervention group receive access to a
12-week Internet-based self-help treatment (deprexis®)
that is described in more detail elsewhere [32,33]. The
self-help program consists of 10 modules, plus one intro-
ductory and one summary module. The modules cover a
variety of therapeutic content that is broadly consistent
with a cognitive-behavioral perspective, although the pro-
gram is not restricted to one CBT manual. A specific fea-
ture of this interventionthe program is that the content of
the modules is provided in simulated dialogue form, in
which the program explains and illustrates concepts and
techniques, engages the user in exercises, and continu-
ously asks users for feedback. Subsequent content is then
tailored to the users’ responses. Participants can go
through the program at their own speed (i.e., modules are
not gradually made available at a specific schedule; e.g.
one module per week).
The deprexis program is available in an unguided and
in a guided version [33]. The guided version will be
made available to participants with an initial PHQ-9
score of 10–14. It includes a so-called therapist cockpit,
where therapists/coaches can track participants’ program
use and symptomatic progress. The cockpit includes an
integrated and secure email system through which thera-
pists/coaches can communicate with participants. At the
beginning of the treatment, email supporters inform par-
ticipants that they can contact the therapists/coaches
whenever they want to. Participants are also actively
contacted by their e-mail supporter once a week. In this
weekly message, email supporters write short feedback
based on participants’ program usage over the previous
week. The feedback is relatively generic in nature and
does not apply therapeutic strategies in detail. The most
important aspects of this feedback are recognition and
reinforcement of the participants’ independent work
with the self-help program. This support will take 10–
15 minutes per week, resulting in a total coaching time
of about 2.5 hours per participant [33].
The email support will be provided by psychothera-
pists in training or Master of Science students who arein their last term of graduate programs in clinical psych-
ology and psychotherapy. In a first step, all supporters will
receive a training of approximately 4 hours in using the
internet-based self-help program and on how to write the
weekly feedback, based on case material. In a second step,
the supporters are continuously supervised by the investiga-
tor coordinating email-support (TB). He routinely checks
whether the messages written are in accordance with the
treatment protocol and provides feedback to the sup-
porters. In this multicenter study, email support is provided
by three sites (Bern, Trier, Tübingen). Participants receiving
email support will be randomly allocated to one of the 3
sites. However, within each site, participants will be con-
secutively allocated to therapists without randomization to
minimize waiting times.
CAU group
Participants in the CAU group will not receive treatment or
support by the researchers. However, they are free to seek
any other help they desire, including pharmacological and
psychological treatments. All concurrently used treatments
will be measured repeatedly by self-reports. Participants in
the CAU group will receive access to the intervention after
the last follow-up assessment, 12 months after baseline
assessment.
Responses to crises and suicidality
All participants will be advised during the diagnostic
interview on how to receive professional help in case of
a suicidal crisis. They will be required to develop a crisis
plan which includes an address of a local psychotherap-
ist, psychiatrist, general practitioner or hospital they
would contact in case of an acute crisis. In addition, an
email hotline is available every weekday for the partici-
pants of the study in case of an acute crisis. This email
hotline answers simple queries directly and directs par-
ticipants to experts should the need arise.
Assessments
There will be a total of four assessments. The first as-
sessment (baseline, T1) will be before the start of the
intervention. Other assessments will take place at
3 months (directly following the intervention, T2),
6 months (T3), and 12 months (T4) after baseline (see
Table 1). All self-report assessments will be performed
via online questionnaires conducted via an online-survey
program (www.unipark.de). At T1, T2 and T3 an add-
itional diagnostic interview will be conducted via tele-
phone in which the Mini International Neuropsychiatric
Interview (MINI) [29], the Hamilton Depression Rating
Scale (HDRS) [30] and the Quick Inventory of Depressive
Symptomatology (QIDS) [34] are administered. All clinical
interviews will be conducted by certified raters. Raters are
advanced university students or graduates majoring in
Table 1 Study assessments and assessment time points
Online self-assessment Clinician assessment via telephone
PHQ-9 WSQ D-CAT SF-12 APOI FEP-2 WAI-S1,2 ZUF-81 Ressource use HRSD QIDS MINI
T1 baseline X X X X X X X X X X
Post randomisation X
T2 post-intervention X X X X X X X X X X X X
Monthly X
T3 three month follow-up X X X X X X X
Monthly X
T4 nine month follow-up X X X X X X X X X
1Only patients randomized to the online psychological intervention.
2Only patients with moderate symptoms (PHQ-9 10–14) who also get e-mail-support.
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ing, including at least one audiotaped interview and the ob-
servation of ratings by experienced raters. In addition to
the four outcome assessments, the primary outcome meas-
ure (PHQ-9) will be administered weekly in the interven-
tion group via the online intervention and monthly for
both groups during the follow-up period via a link to an
online-survey that is sent via email automatically.
Outcome measurements
Primary outcome
Depressive symptoms Symptoms of depression will be
measured with the Patient Health Questionnaire (PHQ-
9) [26]. The PHQ-9 is a self-administered version of the
PRIME-MD diagnostic instrument for common mental
disorders [2,26]. The PHQ-9 is the depression module,
which scores at each of the 9 DSM-IV criteria on a 4-point
Likert-scale from “0” (not at all) to “3” (nearly every day)
[2]. The PHQ-9 score can thus range from 0 to 27. The
PHQ-9 has been shown to be sensitive to change [35-38].
It can also be used as a diagnostic algorithm to make a
probable diagnosis of a depressive episode [26]. The pri-
mary outcome measure (PHQ-9) will be administered
once per month during the follow-up period (after the ini-
tial 12 weeks) to allow for a relatively fine-grained analysis
of symptom fluctuations over time.
Secondary outcomes
Diagnostic status
Mini International Neuropsychiatric Interview (MINI)
The MINI is a short structured diagnostic interview, de-
veloped for DSM-IV and ICD-10 psychiatric disorders
[29]. In the interest of efficiency, an abbreviated version
of the MINI is administered to establish the presence of
the inclusion and exclusion criteria. Specifically, we as-
sess the presence of a current depressive episode or dys-
thymia (Module A and B), a manic episode (Module D),
a psychotic episode/schizophrenia (Module L) and acute
suicidality (Module C). For the follow-up interview (T4),
only the MINI Modules A and B are used to assessdepressives episodes and dysthymia longitudinally. The
Module A was adapted to detect the presence and onset
of a depressive episode during the follow-up period. Spe-
cifically, the A5-item was modified to assess further epi-
sodes within the last 12 months (as opposed to lifetime
episodes in the original version) and items A1-A4 are
assessed regarding the last 12 months even in the ab-
sence of a current depressive episode (this feature is ab-
sent in the original version).
Web Screening Questionnaire (WSQ) The WSQ is a
15-item self-report instrument screening for frequent men-
tal disorders [39]. Evidence indicating adequate diagnostic
validity has been reported for social phobia, panic disorder
with agoraphobia, agoraphobia without panic disorder,
obsessive-compulsive disorder and alcohol abuse/depend-
ence [sensitivity .72-1.00; specificity .63-.80; 39]. Somewhat
more modest psychometric properties have been reported
for major depressive disorder, generalized anxiety disorder,
posttraumatic stress disorder, specific phobia and panic
disorder without agoraphobia [sensitivity: .80-.93; specifi-
city: .44-.51; 39].
Depressive symptoms
Hamilton Depression Rating Scale (HDRS) The 24-
item version of the HDRS [30,40] is administered during
the telephone interview (HDRS-24). It is an established
clinician-rated assessment of depressive symptom sever-
ity and encompasses psychological as well as somatic
symptoms (scores range from 0–2 or 0–4). Using sever-
ity descriptors, the clinician rates the severity of these
symptoms based on the patient’s report, his or her own
observation and third-party observations if available.
Telephone-administered versions of the HDRS have
been used successfully in previous studies [41]. The 24-
item version is used to allow for comparisons with other
depression trials [42,43].
Quick Inventory of Depressive Symptomatology (QIDS)
The HDRS is complemented by the Quick Inventory of
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QIDS was developed to improve on existing ratings such
as the HDRS by providing equivalent weightings (0–3)
for each symptom item, providing clearly stated anchors
that estimate the frequency and severity of symptoms,
including all DSM-IV criterion items required to diag-
nose a major depressive episode. The 16-item version fo-
cuses on the nine DSM-IV criterion symptom domains
[43,44] and assesses the severity of depressive symptoms
in the last seven days [34].
Computer-adaptive test for depression (D-CAT) Com-
puter Adaptive Tests (CAT) have been developed to
enhance measurement precision and reduce respondent
burden. Based on Item Response Theory (IRT), the
CAT for depression (D-CAT) contains a bank of 64 de-
pression items. These are adaptively administered until
a predetermined reliability is attained. The D-CAT can
be completed quickly (in just over a minute) and is reli-
able after an average administration of only six items
[45]. The CAT-scores correlate highly with the 21-item
Beck Depression Inventory (r = 0.79) and with the
Centre for Epidemiological Studies Depression Scale
(CES-D) 8 item short form (r = 0.76) [46]. Due to
technological difficulties, the D-CAT is administered
only in a subset of participants.
Quality of life
Short-Form Health Survey −12 (SF-12) The SF-12 is
based upon the “Short-Form Health Survey“ (SF-36). Its
two subscales measure physical and mental aspects of
health-related quality of life. It captures general health as
well as pain, disabilities in daily life and mental problems.
The SF-12 asks for the presence and severity of 12 items
over the course of the last 4 weeks. The re-test reliability
is good and it is roughly equivalent to the long form [47].
Health-care utilization
Use of health care resources All participants are self-
reporting use of health-care resources. In a subsample of
patients, participants’ self-report will be compared with
routine administrative data provided by several companies
providing statutory health insurance. Items in the self-
report cover direct (i.e. medication, inpatient and outpatient
treatments) and indirect costs (i.e. days of absence due to
sick leave). This will allow an estimation of direct costs (re-
source use) and indirect costs (productivity loss) [48,49].
Process evaluation
Working Alliance Inventory – Short (WAI-S; adapted
version) The WAI-short (WAI-S) is a 12-item self-report
measure of Working Alliance [50]. Each item is rated on a
7 point scale, with higher scores indicating higher alliance.
The WAI is scored into three subscales measuring Task,Goal and Bond. The Task and Goal scales are intended to
measure agreement between the client and therapist with
regard to Tasks and Goals of the treatment. The Bond
subscale aims to measure the empathic bond between the
client and the therapist [51]. We have adapted the scale by
mildly reframing the items to assess internet treatment in-
stead of face-to-face treatment. The WAI will only be ad-
ministered to participants receiving guidance.
Patient satisfaction questionnaire (ZUF-8) The ZUF-8
is a brief and reliable test-instrument to measure general sat-
isfaction with treatment [52]. It was originally developed as a
modified translation of the 8-item version of the Client Satis-
faction Questionnaire [53] to assess satisfaction with in-
patient treatment. It was adapted for this study to assess the
satisfaction with the online-based psychological intervention.
Other outcomes
Questionnaire for the evaluation of psychotherapeutic
progress (FEP-2) The FEP-2 is a measure of therapeutic
progress, it can be used for both change and outcome
assessment [54,55]. Forty items measure the dimensions
well-being, symptoms, interpersonal relationships, and
incongruence with respect to approach and avoidance
goals. The instrument has shown to be change sensitive
as well as reliable and it is available in the public do-
main. It represents the phase model of therapeutic
change as well as interpersonal and integrative models
of psychotherapy [56].
Attitudes toward Psychological Online-Interventions
Questionnaire (APOI) This questionnaire will be devel-
oped based on the sample of the EVIDENT study. The
development version consists of 35 items that aim at
measuring attitudes towards internet-based self-help
programs. After conducting exploratory and confirma-
tory factor analyses at the end of recruitment, the
revealed latent structure of multiple factors will be ap-
plied to measure changes in participants’ attitudes to-
ward psychological online-interventions on different
dimensions. Beyond that, the aim is to identify manifes-
tations on particular attitude dimensions that are ob-
structive or beneficial for the individual efficacy of
internet-based self-help programs.
Other questions Patients are self-reporting a number of
demographic variables including sex, marital status, and
level of education. They are also asked about the use of
other treatments and medication, and about the referral
source and internet usage.
Sample size
The sample size is conservatively based on the expected
difference between the intervention and the care-as-usual
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symptoms measured with the PHQ-9). Although the inter-
vention evaluated in this study also includes guidance for
some of the participants, the between-group effect size es-
timate is based on meta-analytic evidence for the effect
observed in unguided psychological interventions (d =
0.28) [22]. Because treatments effects in a sample with
mild to moderately depressed participants could even be
lower, we conservatively reduced the estimated effect size
to d = 0.23. Based on this effect size, a power of 0.80, and
an alpha level of 0.05, we would need 300 subjects in each
condition. Sample size was further estimated based on a
drop-out rate of 40%. Drop-out rates in previous studies
of the intervention used in this study range from 9% [33]
to 45% [32], thus this estimate is rather conservative. Pre-
vious research shows that drop-out rates are lower in the
control group [14]. Based on this assumption, we will need
a total of 1000 subjects. The sample size was calculated
using G-Power [57]. Based on prior experience of users of
the intervention, we expect a non-eligible rate of 70% and
may therefore have to screen 3333 participants.
Statistical analysis
A statistical plan will be developed and put down in
writing prior to the analysis of the data. The main ana-
lyses will be conducted on the intention-to-treat sample.
A linear mixed-model repeated measures ANOVA with
time (T1-T2-T3-T4) as a within groups factor and treat-
ment condition as a between-groups factor will be used
for the main research question. Mixed-model repeated
measures ANOVA uses all available data of each subject
and does not involve the substitution of missing values.
Sensitivity analysis will be conducted to analyze the im-
pact of drop-outs on our results. Secondary analyses of
the primary endpoint will include a per-protocol ap-
proach. Per-protocol analysis will be based on full data-
sets of participants who used at least two sessions of the
online-based psychological intervention for a complete
duration of at least 60 minutes. The analysis of time to
onset of a depressive episode and time to remission of
depressive episode will be analyzed using survival ana-
lysis techniques. The time to onset of depressive episode
will be based on monthly PHQ-9 assessments (these
allow the assessment of a probable presence or absence
of a depressive episode [26]) and retrospective assess-
ment of the onset of MDE during the final telephone
interview (T4). Significance testing of dichotomous data
such as diagnostic status will be conducted with chi-
square tests. Calculations of within- and between-groups
effect sizes (Cohen’s d) will be based on the pooled stand-
ard deviations. Regression analyses will be used to identify
predictors of treatment outcome. To analyse the use of
health-care resources descriptive methods such as abso-
lute and relative frequency scales, measures of dispersionor measures of central tendency will be used. In order to
investigate differences between various patient subgroups
appropriate statistical tests will be applied. The assortment
of the test will depend on the character of the routine ad-
ministrative data. All analyses will be performed with SPSS
statistics, Excel and Visual Basic for Applications (VBA).
Discussion
This randomized-controlled multicenter study examines
the effectiveness of an online psychological intervention in
controlling mild to moderate depressive symptoms and
preventing emergence and relapse of depression. It is one
of the first large trials examining the impact of online self-
help interventions on health economic measures [58]. We
will also gain valuable experiences in implementing an on-
line psychological intervention into routine clinical care.
As a major strength of this study, it has a low-threshold
of entry as anyone suffering from depressive symptoms
can sign up through the study website without further re-
quirements. We will therefore be able to draw inferences
with regard to the effectiveness of online-psychological
treatments, i.e. the extent to which the treatment achieves
its intended effect in the usual clinical setting [59]. To this
end, we will include patients with other comorbid disor-
ders including substance abuse and dependence, anxiety
disorders and personality disorders. Also, acute suicidality
will be assessed clinically by trained interviewers rather
than based on a more rigid exclusion of all patients who
cross a certain threshold on a self-rating. These measures
will improve the external validity of our study results as
the great majority of patients with depression suffer from
at least one comorbid mental disorder (41). This strength
of the study may also be regarded as a limitation, as it may
result in a relatively heterogeneous group of patients. An-
other weakness of our design is the liberal acceptance of
concomitant treatments in our study, which again will in-
crease the external validity of our findings while possibly
reducing internal validity.
In addition to the main analysis described in the methods
section, our study will be able to address a number of other
important research questions, some of which have not been
addressed before. To this end, we will conduct subgroup
analyses of the influence of pre-specified baseline character-
istics on the main outcome measure [60] and analyses of
secondary outcomes. One subgroup analysis will concern
the influence of referral source (medical and psychological
services versus other) and primary motivation for study
participation (self versus other) on the main outcome as
many trials of online-based psychological interventions
have been conducted outside routine clinical practice [22]
and the applicability of the results to routine clinical prac-
tice has therefore been debated [61]. Other subgroup ana-
lysis will concern the influence of baseline severity [14],
presence of depressive episode at baseline, chronicity [62],
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http://www.biomedcentral.com/1471-244X/13/239parallel treatment [24] and attitude to online psychological
intervention [63] on the main outcome.
We also plan to undertake a wide range of additional
analyses. Weekly PHQ assessments in the intervention
group will allow us to identify meaningful patterns of early
change in depression during online treatment that are
shared by many individual patients and examine whether
these patterns predict outcomes at treatment termination
and over the follow-up period as well as drop-out or time
patients participate in online treatment [64,65]. Also we
may be able to assess whether e-mail support affects work-
ing alliance scores and attitudes towards online psycho-
logical interventions. The results of this analysis will be
biased by depression severity however as only more se-
verely depressed participants receive e-mail support. Finally,
this study will be the first to use the Computer-adaptive test
for depression (D-CAT) [45,46] in a prospective random-
ized controlled trial and will allow the comparison with
more established outcome measures.
The present trial will probably be the largest multicentric
study conducted thus far of an online depression treatment
in which validated diagnostic interviews and symptom se-
verity measures are used and participants are followed for a
full year (without those in the control group receiving the
intervention). It is hoped that the study will yield meaning-
ful answers to the question of whether the internet-based
intervention studied here can contribute to the effective
and efficient prevention and treatment of mild to moderate
depression on a population level. The results of this trial
are expected to influence policy decisions with regard to
whether such interventions ought to be implemented more
widely in order to meet the challenge posed by the global
depression treatment gap.
Trial status
Currently recruiting (Ncurrent = 796 as of September
5th 2013).
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